Department for Social Sphere, Trade and Non-productive Services
Head of the Department - Ms. Nadezhda Sharavskaya
Deputy Head of the Department - Ms. Yulia Ermakova
Deputy Head of the Department - Ms. Daria Selivanova
Deputy Head of the Department - Ms. Yulia Ermakova
Deputy Head of the Department - Ms. Daria Selivanova
21.07.2016
Appeal Court confirmed FAS conclusions on substitutability of medicinal drugs with different presentationsmore![Appeal Court confirmed FAS conclusions on substitutability of medicinal drugs with different presentations](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/lori_0003461000_smallwww_4_7.jpg)
“The process was very complicated because for the first time we had to prove at Court the equivalence of different preparations"
more
21.07.2016
FAS explained the drug pricing procedure when a decision on a negotiated price is withdrawn more![FAS explained the drug pricing procedure when a decision on a negotiated price is withdrawn](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/kapsula_lekarstvo.jpg)
FAS published an explanation on its official web-site on the procedure for selling “Ursosan” medicine made by “PRO.MED.CS” Prague a.s. (the Czech Republic) due to withdrawing a decision on negotiated maximum ex-works prices made by the Federal Tariff Service on 7 July 2015.
more
![Appeal Court legitimize FAS refusal to register overrated prices for medicinal drugs](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/blister.jpg)
On 5 July 2016, the 9th Arbitration Appeal Court upheld the judgment of Moscow Arbitration Court and pronounced legitimacy of the refusal of the Federal Antimonopoly Service (FAS Russia) to approve the maximum ex-works prices for “Ciprofloxacin” and “Metronidazole” medicinal drugs made by “Elfa Laboratories” (India) upon a petition of “Elfa” Research-and-Production Centre” JSC.
more
![FAS found that “Lenta” Ltd. Violated the Law on Trade](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/lenta2.jpg)
On 22 June 2016 the Federal Antimonopoly Service (FAS Russia) found that “Lenta” Ltd. Violated Claus 1 Part 1 Article 13 of the Law on Trade (creation of discriminatory conditions).
more
![The Ministry of Health Care executed a warning of the antimonopoly authority](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/lori-0007176482-cut.jpg)
"Pharmaceutical manufacturers who earlier received unreasonable refusals can again approach the Ministry to make changes to a Register entry"
more